(Q52006433)

19 April 2018

title

TNFalpha DNA vaccination prevents clinical manifestations of experimental antiphospholipid syndrome. (English)

1 reference

19 April 2018

5

Y Shoenfeld

1 reference

19 April 2018

1

M Blank

1 reference

19 April 2018

2

I Krause

1 reference

19 April 2018

G Wildbaum

3

1 reference

19 April 2018

N Karin

series ordinal

4

1 reference

19 April 2018

publication date

1 January 2003

1 reference

19 April 2018

published in

Lupus

1 reference

19 April 2018

volume

12

1 reference

19 April 2018

issue

7

1 reference

19 April 2018

page(s)

546-549

1 reference

19 April 2018

Anti-idiotype immunomodulation of experimental anti-phospholipid syndrome via effect on Th1/Th2 expression

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU399OA

The pathophysiology of tumor necrosis factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU399OA

Augmentation of natural immunity to a pro-inflammatory cytokine (TNF-alpha) by targeted DNA vaccine confers long-lasting resistance to experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU399OA

Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU399OA

Monoclonal anti-endothelial cell antibodies from a patient with Takayasu arteritis activate endothelial cells from large vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU399OA

Suppression of experimental systemic lupus erythematosus (SLE) in mice via TNF inhibition by an anti-TNFalpha monoclonal antibody and by pentoxiphylline

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU399OA

10.1191/0961203303LU399OA

21 January 2018

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018